Human parvovirus B19 infection of monocytic cell line U937 and antibody-dependent enhancement

Virology

Volumn 345, Issue 1, 2006, Pages 251-257

  Munakata, Yasuhiko ^a   Kato, Ichiro ^a   Saito, Takako ^a   Kodera, Takao ^a   Ishii, Keiko Kumura ^a   Sasaki, Takeshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antibody dependent enhancement; Parvovirus B19; TNF

Indexed keywords

ANTIBODY; DNA; IMMUNOGLOBULIN G ANTIBODY; MESSENGER RNA; RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LINE; CONTROLLED STUDY; DNA REPLICATION; ERYTHEMA INFECTIOSUM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MONOCYTE; PRIORITY JOURNAL; VIRUS REPLICATION;

ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; CELL LINE; DNA, VIRAL; HUMANS; MONOCYTES; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

ALPHAVIRUS; PARVOVIRUS;

EID: 30844465052     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.09.040     Document Type: Article

References (32)

1. M.J. Anderson, P.G. Higgins, L.R. Davis, J.S. Willman, S.E. Jones, I.M. Kidd, J.R. Pattison, and D.A. Tyrrell Experimental parvovirus infection to humans J. Infect. Dis. 152 1985 257 265
2. K.E. Brown, and N.S. Young Parvovirus B19 in human disease Annu. Rev. Med. 48 1997 59 67
3. K.E. Brown, S.M. Anderson, and N.S. Young Erythrocyte P antigen: cellular receptor for B19 parvovirus Science 5130 1993 114 117
4. S.M. Cancel Tirado, and K.-J. Yoon Antibody-dependent enhancement of virus infection and disease Viral. Immunol. 16 2003 69 86
5. Y. Fu, K.K. Ishii, Y. Munakata, T. Saito, M. Kaku, and T. Sasaki Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2 J. Virol. 76 2002 5395 5403
6. S.B. Halstead Pathogenesis of dengue: challenges to molecular biology Science 239 1988 476 481
7. S.B. Halstead, and E.J. O'Rourke Antibody-enhanced dengue virus infection in primate leukocytes Nature 265 1977 739 741
8. R.A. Hawkes Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls Aust. J. Exp. Biol. Med. Sci. 42 1964 465 482
9. H. Isumi, T. Nunoue, A. Nishida, and S. Takahashi Fetal brain infection with human parvovirus B19 Pediatr. Neurol. 21 1999 661 663
10. L.B. Johnson, A. Pasumarthy, and L.D. Saravolatz Parvovirus B19 infection presenting with necrotizing lymphadenitis Am. J. Med. 114 2003 340 341
11. H. Kanno, J.B. Wolfinbarger, and M.E. Bloom Aleutian mink disease parvovirus infection of mink macrophages and human macrophage cell line U937: demonstration of antibody-dependent enhancement of infection J. Virol. 67 1993 7017 7024
12. J.R. Kerr Pathogenesis of human parvovirus B19 in rheumatic disease Ann. Rheum. Dis. 59 2000 672 683
13. C. Larroche, C. Scieux, P. Honderlick, A.M. Piette, F. Morinet, and O. Bletry Spontaneous resolution of hemophagocytic syndrome associated with acute parvovirus B19 infection and concomitant Epstein-Barr virus reactivation in an otherwise healthy adult Eur. J. Clin. Microbiol. Infect. Dis. 21 2002 739 742
14. J.D. Lay, C.J. Tsao, J.Y. Chen, M.E. Kadin, and I.J. Su Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome J. Clin. Invest. 100 1997 1969 1979
15. H.W. Lehmann, P. Von Landenberg, and S. Modrow Parvovirus B19 infection and autoimmune disease Autoimmun. Rev. 2 2003 218 223
16. J.A. Lopez-Guerrero, F.X. Pimental-Muinos, M. Fresno, and M.A. Alonso Role of soluble cytokines on the restricted replication of poliovirus in the monocytic U937 cell line Virus Res. 16 1990 225 230
17. J.A. Lopez-Guerrero, B. Rayet, M. Tuynder, J. Rommelaere, and C. Dinsart Constitutive activation of U937 promonocytic cell clones selected for their resistance to parvovirus H-1 infection Blood 89 1997 1642 1653
18. E. Miyagawa, T. Yoshida, H. Takahashi, K. Yamaguchi, T. Nagano, Y. Kiriyama, K. Okochi, and H. Sato Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity J. Virol. Methods 83 1999 45 54
19. D.J. Mock, F. Domurat, N.J. Roberts Jr., E.E. Walsh, M.R. Licht, and P. Keng Macrophages are required for influenza virus infection of human lymphocytes J. Clin. Invest. 79 1987 620 624
20. S. Moffatt, N. Yaegashi, K. Tada, N. Tanaka, and K. Sugamura Human parvovirus B19 nonstructural protein NS1 induces apoptosis in erythroid lineage cells J. Virol. 72 1998 3018 3028
21. H. Ochiai, M. Kurokawa, K. Hayashi, and S. Niwayama Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1 J. Virol. 62 1988 20 26
22. K. Ozawa, J. Ayub, S. Kajigaya, T. Shimada, and N.S. Young The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells J. Virol. 62 1988 2884 2889
23. J.S. Peiris, S. Gordon, J.C. Unkeless, and J.S. Porterfield Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages Nature 289 1981 189 191
24. J.S. Porterfield Antibody-mediated enhancement of rabies virus Nature 290 1981 542
25. N.B. Ray, D.R. Nieva, F.A. Seftor, Z. Khalkhali-Ellis, and S.J. Naides Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts Arthritis Rheum. 44 2001 1582 1586
26. S.L. Rhode III, and P.R. Paradiso Parvovirus replication in normal and transformed human cells correlates with the nuclear translocation of the early protein NS1 J. Virol. 63 1989 349 355
27. W.E. Robinson Jr., D.C. Montefiori, and W.M. Mitchell Antibody-dependent enhancement of human immunodeficiency virus type 1 infection Lancet 1 1988 790 794
28. T. Saito, Y. Munakata, Y. Fu, H. Fujii, T. Kodera, E. Miyagawa, K.K. Ishii, and T. Sasaki Evaluation of anti-parvovirus B19 activity in sera by assay using quantitative polymerase chain reaction J. Virol. Methods 107 2003 81 87
29. R.O. Shade, M.C. Blundell, S.F. Cotmore, P. Tattersall, and C.R. Astell Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis J. Virol. 58 1986 921 936
30. Y. Takahashi, C. Murai, S. Shibata, Y. Munakata, T. Ishii, K.K. Ishii, T. Saito, T. Sawai, K. Sugamura, and T. Sasaki Human parvovirus B19 as a causative agent for rheumatoid arthritis Proc. Natl. Acad. Sci. U.S.A. 95 1998 8227 8232
31. A. Takeda, C.U. Tuazon, and F.A. Ennis Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry Science 242 1988 580 583
32. K.A. Weigel-Kelley, M.C. Yoder, and A. Srivastava Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells J. Virol. 75 2001 4110 4116